Rheumnow

Highlight presentations from ACR 2024 in Washington, DC Covered abstracts include: - Dr. Kavanaugh 1679 Amplified & biomarkers 0082 Enthesitis Pathology & IL-23 1553 TLR 7/8 inhibitors in SLE 995 Carbon footprint to injectables L20 ARTHUR DIANA Automated US 1132 VEGA (Combo Rx – see also 2640, 1460, 1393) 1745 Statin use in Oral Surveillance - Dr. Cush 458 Seronegative RA fate L19 Emapalumab in Stills disease ACR 2024 updated guidelines on lupus nephritis 2580 Ianalumab in SLE 2259 Anti-Obesity Meds in RA 2657 Mortality with starting/stopping steroids 0774  TAPIR study in GCA 1697  PMR MODE study